Dr. Andre J. Gauri, M.D.
Cardiac Electrophysiology (Clinical Cardiac Electrophysiology Physician)
- Medicare participating
At a glance
- Medical school
- Loyola University of Chicago, Stritch School of Medicine (1997)
- Years since graduation
- 29
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 659
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1997Medical school: Loyola University of Chicago, Stritch School of Medicine
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Clinical Cardiac Electrophysiology Physician primary
MI license 4301086331 -
Cardiovascular Disease Physician
MI license 4301086331
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Spectrum Health Grand Rapids, MI
- Spectrum Health United Hospital Greenville, MI
- Corewell Health Big Rapids Hospital Big Rapids, MI
- Corewell Health Ludington Hospital Ludington, MI
- Corewell Health Reed City Hospital Reed City, MI
Medical groups
- Spectrum Health Primary Care PArtners (2,294 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 659
- Services billed
- 1,636
- Patients’ average age
- 76
| Service | Times | Patients |
|---|---|---|
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 575 | 238 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 402 | 150 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 315 | 253 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 255 | 98 |
| Programming of dual lead pacemaker system | 127 | 93 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 121 | 114 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 106 | 33 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 87 | 33 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 84 | 81 |
| Programming of dual lead implantable defibrillator system | 51 | 39 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Eliquis (apixaban) Other prescribers in Grand Rapids, MI | 558 |
| Metoprolol Succinate Other prescribers in Grand Rapids, MI | 323 |
| Xarelto (rivaroxaban) Other prescribers in Grand Rapids, MI | 196 |
| Flecainide Acetate Other prescribers in Grand Rapids, MI | 195 |
| Amiodarone Hcl Other prescribers in Grand Rapids, MI | 152 |
| Dofetilide | 103 |
| Diltiazem 24hr Er (Cd) (diltiazem hcl) Other prescribers in Grand Rapids, MI | 95 |
| Sotalol (sotalol hcl) Other prescribers in Grand Rapids, MI | 67 |
| Digoxin Other prescribers in Grand Rapids, MI | 32 |
| Metoprolol Tartrate Other prescribers in Grand Rapids, MI | 25 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 6 companies reported 59 payments worth $7,362 in total to this clinician.
| Boston Scientific Corporation | $3,408 |
|---|---|
| Medtronic, Inc. | $2,171 |
| Abbott Laboratories | $1,402 |
| Biosense Webster, Inc. | $343 |
| E.r. Squibb & Sons, L.l.c. | $21.58 |
| Pfizer Inc. | $16.31 |
| Consulting Fee | $3,125 |
|---|---|
| Food and Beverage | $2,992 |
| Travel and Lodging | $1,244 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Boston Scientific Corporation Jun 26, 2025 | Consulting Fee General - Therapies · General - Therapies_CRM | $1,250 |
| Boston Scientific Corporation Dec 11, 2025 | Consulting Fee General - Therapies · General - Therapies_Non Divisional | $1,250 |
| Boston Scientific Corporation Dec 11, 2025 | Consulting Fee General - Therapies · General - Therapies_Non Divisional | $625 |
| Abbott Laboratories Aug 21, 2025 | Travel and Lodging AVEIR · Structural Heart · travel to Chiago, IL · in-kind | $274 |
| Medtronic, Inc. Nov 19, 2025 | Travel and Lodging EVERA MRI XT DR SURESCAN · Implantable Cardioverter Defibrillators (ICDs) · travel to Orlando, FL · in-kind | $261 |
| Abbott Laboratories Sep 26, 2025 | Travel and Lodging AVEIR · Structural Heart · travel to Chicago, IL · in-kind | $238 |
| Medtronic, Inc. Oct 23, 2025 | Travel and Lodging EVERA MRI XT DR SURESCAN · Implantable Cardioverter Defibrillators (ICDs) · travel to Orlando, FL · in-kind | $193 |
| Medtronic, Inc. Oct 23, 2025 | Travel and Lodging EVERA MRI XT DR SURESCAN · Implantable Cardioverter Defibrillators (ICDs) · travel to Orlando, FL · in-kind | $126 |
| Medtronic, Inc. Nov 19, 2025 | Travel and Lodging EVERA MRI XT DR SURESCAN · Implantable Cardioverter Defibrillators (ICDs) · travel to Orlando, FL · in-kind | $59.89 |
| Medtronic, Inc. Dec 6, 2025 | Travel and Lodging travel to Orlando, FL · in-kind | $46.00 |
All 12 payments other than meals, newest first
| Company | What it was for | Amount |
|---|---|---|
| Boston Scientific Corporation Dec 11, 2025 | Consulting Fee General - Therapies · General - Therapies_Non Divisional | $1,250 |
| Boston Scientific Corporation Dec 11, 2025 | Consulting Fee General - Therapies · General - Therapies_Non Divisional | $625 |
| Medtronic, Inc. Dec 6, 2025 | Travel and Lodging travel to Orlando, FL · in-kind | $46.00 |
| Medtronic, Inc. Nov 21, 2025 | Travel and Lodging EVERA MRI XT DR SURESCAN · Implantable Cardioverter Defibrillators (ICDs) · travel to Orlando, FL · in-kind | $36.59 |
| Medtronic, Inc. Nov 19, 2025 | Travel and Lodging EVERA MRI XT DR SURESCAN · Implantable Cardioverter Defibrillators (ICDs) · travel to Orlando, FL · in-kind | $261 |
| Medtronic, Inc. Nov 19, 2025 | Travel and Lodging EVERA MRI XT DR SURESCAN · Implantable Cardioverter Defibrillators (ICDs) · travel to Orlando, FL · in-kind | $59.89 |
| Medtronic, Inc. Oct 23, 2025 | Travel and Lodging EVERA MRI XT DR SURESCAN · Implantable Cardioverter Defibrillators (ICDs) · travel to Orlando, FL · in-kind | $193 |
| Medtronic, Inc. Oct 23, 2025 | Travel and Lodging EVERA MRI XT DR SURESCAN · Implantable Cardioverter Defibrillators (ICDs) · travel to Orlando, FL · in-kind | $126 |
| Abbott Laboratories Sep 26, 2025 | Travel and Lodging AVEIR · Structural Heart · travel to Chicago, IL · in-kind | $238 |
| Abbott Laboratories Aug 21, 2025 | Travel and Lodging AVEIR · Structural Heart · travel to Chiago, IL · in-kind | $274 |
| Abbott Laboratories Aug 21, 2025 | Travel and Lodging AVEIR · Structural Heart · travel to Chiago, IL · in-kind | $9.02 |
| Boston Scientific Corporation Jun 26, 2025 | Consulting Fee General - Therapies · General - Therapies_CRM | $1,250 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 3 industry-funded studies in 2025, from 2 companies. The companies reported $95,489 in research payments for these studies, mostly to the institutions running them.
- Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation
Boston Scientific Corporation · Active, not recruiting · NCT06096337 - Cryo AF Global Registry
Medtronic, Inc. - Cryo-AF
Medtronic, Inc.
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.